Cargando…

Effectiveness of COVID-19 vaccination during pregnancy by circulating viral variant

BACKGROUND: SARS-CoV-2 infection in pregnancy can result in a spectrum of asymptomatic to critical COVID-19 outcomes, including hospitalization, admission to the intensive care unit, or death. OBJECTIVE: This study aimed to investigate the effectiveness of messenger RNA COVID-19 vaccination during p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zerbo, Ousseny, Ray, G. Thomas, Fireman, Bruce, Layefsky, Evan, Goddard, Kristin, Ross, Pat, Greenberg, Mara, Klein, Nicola P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502365/ https://www.ncbi.nlm.nih.gov/pubmed/37719643 http://dx.doi.org/10.1016/j.xagr.2023.100264

Ejemplares similares

504. Individual and Neighborhood Factors Associated with Failure to Vaccinate Against COVID-19 Among Pregnant Persons
por: Zerbo, Ousseny, et al.
Publicado: (2023)

Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons
por: Zerbo, Ousseny, et al.
Publicado: (2023)

Maternal SARS-CoV-2 Vaccination and Infant Protection Against SARS-CoV-2 During the First 6 Months of Life
por: Zerbo, Ousseny, et al.
Publicado: (2022)

Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life
por: Zerbo, Ousseny, et al.
Publicado: (2023)

2297. COVID-19 Vaccine Effectiveness Among Pregnant People
por: Zerbo, Ousseny, et al.
Publicado: (2022)

Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season
por: Klein, Nicola P., et al.
Publicado: (2020)

LB15. Vaccine Effectiveness of Flucelvax Relative to Inactivated Influenza Vaccine During the 2017–18 Influenza Season in Northern California
por: Klein, Nicola P, et al.
Publicado: (2018)

2766. Identification and Description of Mumps Cases in a Non-Outbreak Setting and Evaluation of the Effectiveness of Mumps Containing Vaccines Over Time
por: Zerbo, Ousseny, et al.
Publicado: (2019)

Identification and description of mumps cases in a non-outbreak setting and evaluation of the effectiveness of mumps-containing vaccines over time
por: Zerbo, Ousseny, et al.
Publicado: (2020)

Population‐based assessment of risks for severe COVID‐19 disease outcomes
por: Zerbo, Ousseny, et al.
Publicado: (2021)

177. Safety of Measles and Pertussis-containing Vaccines in School-age Children Previously Diagnosed with Autism Spectrum Disorders
por: Zerbo, Ousseny, et al.
Publicado: (2020)

Parental risk factors for fever in their children 7–10 days after the first dose of measles-containing vaccines
por: Zerbo, Ousseny, et al.
Publicado: (2019)

2275. Parental Risk Factors for Fever in their Children 7–10 Days After the First Dose of Measles-Containing Vaccines
por: Zerbo, Ousseny, et al.
Publicado: (2018)

2649. Measles-Containing Vaccination Resulted in a Balanced Cytokine Profile Without Evidence of Immunosuppression in Healthy 12-Month-Old Children
por: Gans, Hayley, et al.
Publicado: (2019)

Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination
por: Goddard, Kristin, et al.
Publicado: (2022)

Genetic associations with a fever after measles-containing vaccines
por: Klein, Nicola P., et al.
Publicado: (2020)

Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink
por: Kenigsberg, Tat'Yana A., et al.
Publicado: (2023)

Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States
por: Schrag, Stephanie J., et al.
Publicado: (2022)

COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 15, 2021
por: Pingali, Cassandra, et al.
Publicado: (2021)

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination
por: Hansen, John, et al.
Publicado: (2021)

Polychlorinated Biphenyl and Organochlorine Pesticide Concentrations in Maternal Mid-Pregnancy Serum Samples: Association with Autism Spectrum Disorder and Intellectual Disability
por: Lyall, Kristen, et al.
Publicado: (2016)

Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink
por: Hanson, Kayla E., et al.
Publicado: (2022)

2322. Effectiveness of Recombinant Influenza Vaccine vs. Standard Dose Inactivated Influenza Vaccines Against Hospitalized Influenza-Related Outcomes in Adults: A Cluster Randomized Trial
por: Hsiao, Amber, et al.
Publicado: (2022)

Antibiotic prescribing across age groups in the Kaiser Permanente Northern California population in association with different diagnoses, and with influenza incidence, 2010–2018
por: Goldstein, Edward, et al.
Publicado: (2022)

Prescribing for different antibiotic classes across age groups in the Kaiser Permanente Northern California population in association with influenza incidence, 2010–2018
por: Goldstein, Edward, et al.
Publicado: (2022)

Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records
por: Klein, Nicola P, et al.
Publicado: (2023)

Associations of COVID-19-Related Health, Healthcare and Economic Factors With Prenatal Depression and Anxiety
por: Avalos, Lyndsay A., et al.
Publicado: (2022)

Live Attenuated Influenza Vaccination Before 3 Years of Age and Subsequent Development of Asthma: A 14-year Follow-up Study
por: Baxter, Roger P., et al.
Publicado: (2018)

22. An Innovative Approach to Examining the Waning of Vaccine Effectiveness Using Automated Healthcare Data
por: Aukes, Laurie, et al.
Publicado: (2021)

2743. Safety of Recombinant Influenza Vaccine Compared with Inactivated Influenza Vaccine in Adults
por: Hansen, John, et al.
Publicado: (2019)

2481. Impact of Sex and Race/Ethnicity on the Effectiveness of Live Zoster Vaccine
por: Marks, Morgan A, et al.
Publicado: (2018)

Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy
por: DeSilva, Malini, et al.
Publicado: (2022)

Effectiveness of Live Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus (HZO)
por: Aukes, Laurie, et al.
Publicado: (2017)

1162. Influenza Vaccination Among Pregnant People in the Vaccine Safety Datalink, 2016-17 through 2022-23 Influenza Seasons
por: Irving, Stephanie, et al.
Publicado: (2023)

Contributions of COVID-19 Pandemic-Related Stressors to Racial and Ethnic Disparities in Mental Health During Pregnancy
por: Avalos, Lyndsay A., et al.
Publicado: (2022)

1078 Risk Factors Associated with Developing Fever Following First Dose Measles-Containing Vaccines
por: Klein, Nicola P., et al.
Publicado: (2014)

Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study
por: Baxter, Roger, et al.
Publicado: (2018)

Depletion-of-susceptibles bias in influenza vaccine waning studies: how to ensure robust results
por: Lipsitch, M., et al.
Publicado: (2019)

COVID-19 vaccination in pregnancy
por: Kalafat, Erkan, et al.
Publicado: (2022)

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings
por: Thompson, Mark G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hgmbo1m29a1rr4j3osarmt3cf3